Badger Meter ( (BMI) ) has provided an update. Badger Meter, Inc. announced that it will use a specific investor presentation during its Investor Day scheduled for May 21, 2026, outlining information ...
SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine ...
The American Diabetes Association's annual congress will feature a superstar lineup, including weight loss giants Eli Lilly ...
-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy ---- Weight category improvements observed in ...
-- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy -- -- Rhythm announced plans for a new substudy to ...
-- Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months on setmelanotide therapy; mean BMI decrease of 21.3% in patients (n=5) ...
Poster Presentations Highlight Data from 13-Week Phase 2 VENTURE-Oral Trial of VK2735 and Participant Characteristics from Phase 3 VANQUISH-1 Trial of Subcutaneous VK2735 At ECO, Viking will present a ...
Pablo Picasso died more than 50 years ago, but if he were still with us he would now be painting his subjects with a “GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results